BioSpace News Archive

Business

OncoMyx’s Oncolytic Virus Platform Shows Preclinical Efficacy, Boosting Immunotherapy Potential

Only about one in seven cancer patients today benefit from immunotherapy. OncoMyx aims to increase this number, using a new multi-armed, systemically administered and targeted oncolytic virus.

November 17, 2020
·
4 min read
·
Gail Dutton
Policy

Adamis and Alkermes Eye Adjustments Following Complete Response Letters from FDA

The two companies received Complete Response Letters from the FDA this week, along with Sanofi.

November 17, 2020
·
2 min read
·
Krystle Vermes
Business

Immunic, Inc. Announces Formation of Scientific-Medical Advisory Board

Initial Appointments Include Internationally Recognized Experts: Fred D. Lublin, M.D.; Bruce E. Sands, M.D., M.S.; Jerrold R. Turner, M.D., Ph.D. and Paul J. Utz, M.D.

November 17, 2020
·
11 min read
Business

Imara Announces the Appointment of Lynette Hopkinson as Senior Vice President of Regulatory

Brings 25 years of experience in the pharmaceutical and biotech industries and a deep understanding of global regulatory strategy and commercial regulatory affairs

November 17, 2020
·
4 min read
Genetown

Microbot Medical Secures Patents in Multiple Global Jurisdictions

Microbot Medical Inc. announced that it has received patents in multiple jurisdictions, further demonstrating the Company’s continued execution of expanding and protecting its Intellectual Property portfolio.

November 17, 2020
·
3 min read
Pharm Country

BrainsWay Hosting Key Opinion Leader Call on Deep Transcranial Magnetic Stimulation for Treating Psychiatric Disorders

BrainsWay Ltd. announced that it will host a key opinion leader call on Deep Transcranial Magnetic Stimulation for treating psychiatric disorders on Monday, November 23, 2020, at 10:00 AM Eastern Time.

November 17, 2020
·
6 min read
Policy

DUPIXENT® (dupilumab injection) now approved by Health Canada for patients with severe asthma

Only biologic approved in Canada to treat severe asthma with type 2 / eosinophilic phenotype, or oral corticosteroid-dependent asthma

November 17, 2020
·
4 min read
argenx Premieres A Mystery to Me, a Docuseries Inspired by the Myasthenia Gravis Patient Experience

Created in partnership with Sarofsky Productions, A Mystery to Me explores how three people persevere through the challenges of living with myasthenia gravis, a rare neuromuscular disease

November 17, 2020
·
7 min read
FDA

UCB’s VIMPAT® (lacosamide) CV now approved by FDA for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy

These approvals further help patients with epilepsy who may have had limited treatment options in the past, while reinforcing UCB’s leadership in transforming epilepsy care

November 17, 2020
·
16 min read
Business

Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments

Samsung Biologics’ partnership with Eli Lilly and Company is expected to greatly accelerate the global supply for Lilly’s COVID-19 antibody therapies through a long-term manufacturing agreement, with the ultimate goal of making antibody treatments more globally accessible for patients.

November 17, 2020
·
4 min read